The Product Adoption Lie: Why Great MedTech Fails to Scale

The most common reason breakthrough medical technologies fail to scale isn't poor execution—it's the 'product adoption lie': the dangerous assumption that better products will naturally win in healthcare markets. Holly Miller, founder of Gray Matter Marketing, reveals that adoption must be engineered as deliberately as the product itself, because markets resist change unless they first believe the status quo is broken. She explains how companies like Shockwave Medical transformed their industry by reframing severe arterial calcium as a standalone disease state, not just a procedural hurdle—making their IVL technology the only logical solution. This category design approach shifts focus from competing on features to changing how clinicians perceive the problem, creating inevitable demand. The result? A $13 billion acquisition by J&J. For innovators, the real work begins not at launch, but years before—aligning clinical, regulatory, and commercial teams around a single, urgent narrative that makes the product feel indispensable, not just incremental.